cdphlogo3
California Asthma Partners is managed and supported by California Breathing, a program of the California Department of Public Health

Partner Login



CAP Members

California Asthma Partners (CAP) is a multidisciplinary team of high-level asthma leaders throughout the state guiding implementation of the Strategic Plan for Asthma in California by coordinating statewide efforts. Partners include representatives from fields of medicine, education, advocacy, research and policy. CAP was created in 2004 in response to the need in California for a comprehensive and strategic approach to addressing asthma. 

CAP strives to reflect and represent the asthma interests, geography and diversity of California.

Current CAP members (2010-2011) include:
  • John R. Balmes, MD, Professor, UCSF / San Francisco General Hospital
  • Trina Celise, Acting Executive Director, Asthma & Allergy Foundation of America
  • Joan Edelstein, School Health Consultant
  • Joel Ervice, Associate Director, Regional Asthma Management & Prevention Initiative
  • Anne Farrel-Sheffer, Director, Environmental Health Projects, St. John's  Well Child &Family Centers
  • Eduard J. Flores, Regional Manager of Asthma Programs, American Lung Association in California
  • Joyce J. Gray, Program Director, Ethnic Health Institute
  • Isam A. Herndon, Asthma Advocate, Chairperson
  • Raymond Kohl, Teacher Advisor, Los Angeles Unified School District, Nursing Services Asthma Program
  • Aide Munguia-Fulton, Director, Imperial Valley Child Asthma Program
  •  Jose Luis Olmedo, Executive Director, Comite Civico de Valle
  • Neal Richman, Director of Programs and Advocacy, Breathe California of LA County (Breathe LA), Chairperson elect
  • Terry Roberts, Area Director, American Lung Association in California
  • Margo Sidener, President and CEO, Breathe California of the Bay Area
Non-voting members:

  • Sara Campbell Hicks, Director, California Breathing, CDPH
  • Rick Kreutzer, MD, Chief, Division of Environmental & Occupational Disease Control, CDPH
  • Mary V. Rosas, State Advocacy and Alliance Development, GlaxoSmithKline